RE:RE:RE:RE:RE:fall arrives, back to work I thought Anthony's expertise was to get a large number of investors to PMN and to work through the process of getting PMN listed on NASDAQ. Its been three and a half years and we are not on NASDAQ yet, and so maybe the board thought he doesn't have the time to focus enough on PMN so it's time for him to move on. He is a pretty busy man as you said. See the news from March 2017 below where the term NASDAQ was mentioned twice as his achievement. I was holding shares back then in PMN and my understanding was that he was the guy to take us to NASDAQ.
"Anthony led the up-listing of Cynapsus from the TSX Venture exchange to the TSX and then the NASDAQ, attracting bulge bracket investment banks and some of the largest institutional life science investors in the USA."
Alex1726 wrote:
For a biotech entrepreneur being in a team that will bring a potentially best in class therapy for AD is like a gold minor that thinks will discover a gold mine that has never been discovered before. YOU DO NOT LEAVE